Hot flashes may not be managed adequately in patients treated for breast cancer
the ONA take:
According to a new study conducted by researchers at the University of Southampton in Southampton, United Kingdom, hot flashes experienced by women who have been treated for breast cancer are not being sufficiently addressed by clinicians and some of those women contemplate discontinuing estrogen receptor antagonists in order to stop the hot flashes.
The researchers sought to investigate the disparities between the symptoms the patient experiences and what the clinician recognized and manages. They conducted two surveys with physicians and their patients being treated for breast cancer. Of the physicians surveyed, 94% agreed that hot flashes are not managed adequately. Of the 666 women who were surveyed, 94% experienced hot flashes and 75% said they were a major issue in their life.
Only 25% reported speaking to a health care professional about their hot flashes. Furthermore, about one-third of women who experienced hot flashed contemplated discontinuing their medication to prevent the hot flashes from continuing to occur.
The findings suggest that hot flashes are not being managed adequately by physicians and patients should be encouraged to talk with their physician if they experience hot flashes.
Hot flashes are not being sufficiently addressed by clinicians.
Hot flushes are one of the most distressing conditions faced by women who have been treated for breast cancer, but they are not being adequately addressed by healthcare professionals and some women consider giving up their post cancer medication to try and stop them, a new study by the University of Southampton has shown.
More than 70 per cent of women who have had breast cancer experience menopausal problems, and hot flushes in particular, which are among the most prevalent and potentially distressing problems following breast cancer treatment. These can also be long lasting, persisting for more than five years once cancer treatment has ended and affecting all aspects of life, including sleep, social situations, intimate relationships and ability to work.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|